Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort

J B Olesen; G Y H Lip; P R Hansen; J Lindhardsen; O Ahlehoff; C Andersson; P Weeke; M L Hansen; G H Gislason; C Torp-Pedersen

doi:10.1111/j.1538-7836.2011.04378.x

Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort

J B Olesen, G Y H Lip, P R Hansen, J Lindhardsen, O Ahlehoff, C Andersson, P Weeke, M L Hansen, G H Gislason, C Torp-Pedersen

167 Citations (Scopus)

Abstract

Oral anticoagulation (OAC) in patients with atrial fibrillation (AF) is a double-edged sword, because it decreases the risk of stroke at the cost of an increased risk of bleeding. We compared the performance of a new bleeding prediction scheme, HAS-BLED, with an older bleeding prediction scheme, HEMORR(2)HAGES, in a cohort of 'real-world' AF patients.

Original language	English
Journal	Journal of Thrombosis and Haemostasis
Volume	9
Issue number	8
Pages (from-to)	1460-7
Number of pages	8
ISSN	1538-7933
DOIs	https://doi.org/10.1111/j.1538-7836.2011.04378.x
Publication status	Published - 1 Aug 2011

Access to Document

10.1111/j.1538-7836.2011.04378.x

Cite this

Olesen, J. B., Lip, G. Y. H., Hansen, P. R., Lindhardsen, J., Ahlehoff, O., Andersson, C., Weeke, P., Hansen, M. L., Gislason, G. H., & Torp-Pedersen, C. (2011). Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort. Journal of Thrombosis and Haemostasis, 9(8), 1460-7. https://doi.org/10.1111/j.1538-7836.2011.04378.x

Olesen, JB, Lip, GYH, Hansen, PR , Lindhardsen, J , Ahlehoff, O , Andersson, C , Weeke, P , Hansen, ML , Gislason, GH & Torp-Pedersen, C 2011, 'Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort', Journal of Thrombosis and Haemostasis, vol. 9, no. 8, pp. 1460-7. https://doi.org/10.1111/j.1538-7836.2011.04378.x

@article{4b558740a15b485b8efa2a6b814e9b8f,

title = "Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort",

abstract = "Oral anticoagulation (OAC) in patients with atrial fibrillation (AF) is a double-edged sword, because it decreases the risk of stroke at the cost of an increased risk of bleeding. We compared the performance of a new bleeding prediction scheme, HAS-BLED, with an older bleeding prediction scheme, HEMORR(2)HAGES, in a cohort of 'real-world' AF patients.",

author = "Olesen, {J B} and Lip, {G Y H} and Hansen, {P R} and J Lindhardsen and O Ahlehoff and C Andersson and P Weeke and Hansen, {M L} and Gislason, {G H} and C Torp-Pedersen",

note = "{\textcopyright} 2011 International Society on Thrombosis and Haemostasis.",

year = "2011",

month = aug,

day = "1",

doi = "10.1111/j.1538-7836.2011.04378.x",

language = "English",

volume = "9",

pages = "1460--7",

journal = "Journal of Thrombosis and Haemostasis",

issn = "1538-7933",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "8",

}

TY - JOUR

T1 - Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort

AU - Olesen, J B

AU - Lip, G Y H

AU - Hansen, P R

AU - Lindhardsen, J

AU - Ahlehoff, O

AU - Andersson, C

AU - Weeke, P

AU - Hansen, M L

AU - Gislason, G H

AU - Torp-Pedersen, C

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Oral anticoagulation (OAC) in patients with atrial fibrillation (AF) is a double-edged sword, because it decreases the risk of stroke at the cost of an increased risk of bleeding. We compared the performance of a new bleeding prediction scheme, HAS-BLED, with an older bleeding prediction scheme, HEMORR(2)HAGES, in a cohort of 'real-world' AF patients.

AB - Oral anticoagulation (OAC) in patients with atrial fibrillation (AF) is a double-edged sword, because it decreases the risk of stroke at the cost of an increased risk of bleeding. We compared the performance of a new bleeding prediction scheme, HAS-BLED, with an older bleeding prediction scheme, HEMORR(2)HAGES, in a cohort of 'real-world' AF patients.

U2 - 10.1111/j.1538-7836.2011.04378.x

DO - 10.1111/j.1538-7836.2011.04378.x

M3 - Journal article

C2 - 21624047

VL - 9

SP - 1460

EP - 1467

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

SN - 1538-7933

IS - 8

ER -

Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort

Abstract

Access to Document

Fingerprint

Cite this